News

Results of a meta-analysis of more than 2 dozen studies indicate DCB treatment may actually reduce mortality risk long-term.

A new analysis has found that low blood pressure in older, frail adults could increase mortality risk as much as 63%.

Despite some adverse events, deep brain stimulation is ultimately safe in treating OCD.

In part 2, experts discuss how the public health crisis has reached a third decade, and what plans are to combat addiction problems.

Osilodrostat oral tablets are indicated for the treatment of Cushing's disease in patients not eligible for surgery or in those who still have surgery despite the disease.

A new deep learning system identifies patients with endoscopic and histologic remission with more than 90% accuracy.

A study from EPI Scientific Sessions 2020 is shedding light on the prevalence of certain risk factors among black ethnic groups compared to their white counterparts.

MS patients who experience relapses score significantly lower on the Timed 25-Foot Walk Test.

There is a need for long-term follow-up of bone health for patients undergoing bariatric surgery.

New data from Kaiser Permanente Northern California is quantifying just how much of an impact adherence to each additional guideline can impact patients following AMI.

Patients who switch to congruent medications experience fewer side effects than patients who remain on incongruent medications.

The CDC is preparing for a hypothetical future despite American risk of local transmission not being high presently.

With approval, the new implant becomes the first approved for lowering IOP in patients with open-angle glaucoma and ocular hypertension.

Part 1 of the feature series includes a conversation with Anna Lembke, MD, on the most impactful players and products of the 30-year crisis.

Low fecal intestinal secretory immunoglobin A is commonly found in infants of mothers in the antepartum and persistent depression trajectories.

The label update comes after findings have repeatedly shown an associated risk of neuropsychiatric events.

A new study is diving into differences in long-term outcomes, including remission rates and weight loss, seen among patients undergoing RYGB and SG.

A Mayo Clinic analysis is shedding light on the real-world success of ablation in lowering risk of mortality and HF hospitalizations.

New data evidences yet another IL-13 targeting biologic for atopic dermatitis.

The program can help health systems address the opioid epidemic in the US.

New data from EPI Lifestyle Conference 2020 is shedding light on the impact of initiating estradiol therapy closer to the onset of menopause.

Benefits from HD-IIV might be greater for protection against influenza B/Yamagata and influenza A(H3N2) than for influenza A(H1N1) pdm09.

Exercise training could help individuals in the military maintain function despite a lack of regular sleep.

An analysis of 180,000 patients in South Korea is shedding new light on the potential poor oral hygiene can have on a person's risk of diabetes.

Preliminary data shows blue therapy results in a significant decline in raw depression scores when compared to a placebo.

Approval of isatuximab-irfc (Sarclisa) was based on the results of a 307-person trial, according to a statement from the FDA.

The US Preventive Services Task Force suggested that patients 18-79 years old should be screened regardless of known risk factors.

Everyone has an opinion. But what do the actual experts think?